Goldman Sachs Group Inc Sana Biotechnology, Inc. Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 849,998 shares of SANA stock, worth $2.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
849,998
Previous 817,336 4.0%
Holding current value
$2.87 Million
Previous $4.46 Million 20.78%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$3.76 - $6.86 $122,809 - $224,061
32,662 Added 4.0%
849,998 $3.54 Million
Q2 2024

Aug 13, 2024
SELL
$5.23 - $10.44 $185,351 - $369,993
-35,440 Reduced 4.16%
817,336 $4.46 Million
Q1 2024

May 15, 2024
BUY
$4.2 - $11.27 $94,432 - $253,394
22,484 Added 2.71%
852,776 $8.53 Million
Q4 2023

Feb 13, 2024
BUY
$2.8 - $4.55 $603,820 - $981,207
215,650 Added 35.09%
830,292 $3.39 Million
Q3 2023

May 14, 2024
SELL
$3.77 - $6.23 $813,000 - $1.34 Million
-215,650 Reduced 25.97%
614,642 $2.38 Million
Q3 2023

Nov 14, 2023
SELL
$3.77 - $6.23 $922,168 - $1.52 Million
-244,607 Reduced 28.47%
614,642 $2.38 Million
Q2 2023

May 14, 2024
SELL
$3.22 - $7.53 $376,240 - $879,842
-116,845 Reduced 11.97%
859,249 $5.12 Million
Q2 2023

Aug 14, 2023
SELL
$3.22 - $7.53 $376,240 - $879,842
-116,845 Reduced 11.97%
859,249 $5.12 Million
Q1 2023

May 14, 2024
SELL
$3.11 - $4.92 $2.76 Million - $4.37 Million
-888,404 Reduced 47.65%
976,094 $3.19 Million
Q1 2023

May 11, 2023
SELL
$3.11 - $4.92 $2.76 Million - $4.37 Million
-888,404 Reduced 47.65%
976,094 $3.19 Million
Q4 2022

May 14, 2024
BUY
$3.19 - $6.46 $1.45 Million - $2.93 Million
453,630 Added 32.15%
1,864,498 $7.36 Million
Q4 2022

Feb 13, 2023
BUY
$3.19 - $6.46 $1.45 Million - $2.93 Million
453,630 Added 32.15%
1,864,498 $7.36 Million
Q3 2022

May 14, 2024
BUY
$5.58 - $9.04 $3.12 Million - $5.06 Million
559,841 Added 65.78%
1,410,868 $8.47 Million
Q3 2022

Nov 10, 2022
BUY
$5.58 - $9.04 $3.12 Million - $5.06 Million
559,841 Added 65.78%
1,410,868 $8.47 Million
Q2 2022

May 14, 2024
BUY
$4.12 - $9.35 $85,428 - $193,872
20,735 Added 2.5%
851,027 $5.47 Million
Q2 2022

Aug 15, 2022
BUY
$4.12 - $9.35 $1.05 Million - $2.39 Million
255,738 Added 42.96%
851,027 $5.47 Million
Q1 2022

May 16, 2022
BUY
$5.24 - $15.58 $1.08 Million - $3.21 Million
205,796 Added 52.84%
595,289 $4.92 Million
Q4 2021

Feb 14, 2022
BUY
$15.18 - $23.15 $1.76 Million - $2.69 Million
116,168 Added 42.5%
389,493 $6.03 Million
Q3 2021

Nov 10, 2021
BUY
$16.29 - $25.88 $4.45 Million - $7.07 Million
273,325 New
273,325 $6.16 Million

Others Institutions Holding SANA

# of Institutions
174
Shares Held
121M
Call Options Held
1.87M
Put Options Held
1.48M
View Full List

About Sana Biotechnology, Inc.

SANA Quotes by TradingView
  • Ticker SANA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 190,232,000
  • Market Cap $643M
  • Description
  • Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...
More about SANA
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email